Cumberland Pharmaceuticals (CPIX) Return on Capital Employed Growth (1y) (2012 - 2026)
Cumberland Pharmaceuticals (CPIX) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.61 Mn | 113.74 Mn | - | -1,839.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,839.00 |
| Mar 31, 2026 | -1,137.00 |
| Dec 31, 2025 | 638.00 |
| Sep 30, 2025 | 1,548.00 |
| Jun 30, 2025 | 1,314.00 |
| Mar 31, 2025 | 1,099.00 |
| Dec 31, 2024 | 239.00 |
| Sep 30, 2024 | -1,391.00 |
| Jun 30, 2024 | -1,328.00 |
| Mar 31, 2024 | -884.00 |
| Dec 31, 2023 | -781.00 |
| Sep 30, 2023 | 250.00 |
| Jun 30, 2023 | 635.00 |
| Mar 31, 2023 | 402.00 |
| Dec 31, 2022 | 249.00 |
| Sep 30, 2022 | -451.00 |
| Jun 30, 2022 | -636.00 |
| Mar 31, 2022 | -635.00 |
| Dec 31, 2021 | -246.00 |
| Sep 30, 2021 | 381.00 |